How to Use AI for an Optometrist Practice in 2026: AOA Code of Ethics, FTC Eyeglass Rule + Contact Lens Rule, MIPS MVP, State OD Board Scope, Prior-Auth, and the Owner Scorecard
Published June 8, 2026 · 14 min read
The 7-Layer AI Stack for Modern Optometry Practices
| Layer | Purpose | Tools |
|---|---|---|
| Intake | New-patient + insurance + history | Phreesia + Klara + Weave + 4Patient Care + Solutionreach |
| Ambient SOAP | Ophthalmic exam + refraction | DAX Copilot + DeepScribe + Abridge + Suki + Heidi + Freed + Sunoh.ai |
| EHR + PM | SOAP + Rx + claims + optical POS | RevolutionEHR + Compulink + Crystal PM + Officemate + Eyefinity + eClinicalWorks |
| AI-SaMD | DR + AMD + glaucoma decision support | IDx-DR/Digital Diagnostics + EyeArt/Eyenuk + AEYE + Topcon + Heidelberg + Zeiss |
| Prior-Auth | VSP + EyeMed + Davis + medical PA | VSP/EyeMed/Davis Vision/Spectera + CoverMyMeds + Availity + Cohere + Office Ally |
| Optical Shop | Frame board + AR + reorder | FrameDisplays + GlassesUSA AR + Topology + Visionix Visioffice + EyeQue |
| Outreach | Recall + reviews + scorecard | Weave + Solutionreach + Demandforce + Podium + BirdEye + NiceJob |
10 Copy-Paste Prompts for Optometry Practices
- New-patient intake synthesis — Summarize chief complaint, ocular history (refractive surgery, amblyopia, strabismus), systemic history (diabetes + HTN + autoimmune + thyroid + medications + statins + amiodarone + plaquenil), family history (glaucoma + AMD + retinal detachment), and vision plan vs. medical insurance routing. Output ICD-10 candidates and exam-time estimate.
- Ambient ophthalmic SOAP — Generate SOAP with CPT 92002/92004/92012/92014 ophth E/M (or 99202-99215 with 25 modifier when separate procedure), CPT 92015 refraction, CPT 92020 gonio, CPT 92133/92134 OCT, CPT 92250 fundus, CPT 92083 HVF, CPT 92285 topography, CPT 92310-92313 CL fitting, ICD-10 (H52 + H40 + H35 + E11.31-34 + H10). Cite AOA Optometric Clinical Practice Guidelines.
- FTC Rx release audit — Validate every exam triggers automatic Rx release (Eyeglass Rule 16 CFR 456) + contact lens Rx with signed acknowledgment or 8-hour passive verification (Contact Lens Rule 16 CFR 315 + FCLCA 2020 amendment). Block claim submission if Rx-release log is missing.
- FDA-cleared DR autonomous screening — Auto-route every diabetic patient (E11.x/E10.x) to FDA-cleared autonomous DR screening (IDx-DR / EyeArt / AEYE) for opt-in, with patient consent + Q117 MIPS measure capture + result-to-OD review for any positive. Block use outside FDA label (e.g., type 1 patients under 22 for IDx-DR).
- OCT + VF progression analysis — Generate glaucoma + AMD progression narrative from Heidelberg Spectralis OCT + Zeiss Cirrus + Topcon Triton + HVF GPA + 24-2 SITA-Faster, with risk stratification and AOA glaucoma guideline alignment. OD signs progression call; AI is decision support only.
- Prior-auth + denial appeal — Build PA + appeal for VSP + EyeMed + Davis Vision + Spectera + medical (BCBS + UHC + Aetna + Humana + Medicare Advantage) for medically necessary contact lenses (keratoconus + post-trauma + aphakia + corneal disease), Plaquenil monitoring, OCT + HVF, dry-eye Restasis/Xiidra/Cequa/Miebo/Tyrvaya, and IPL/RF (TearCare + LipiFlow + iLux + OptiLight).
- State OD board scope guardrail — Filter AI suggestions for state OD scope: TPA + oral medications + glaucoma + lasers (LA + KY + OK + AR allow SLT/YAG/LPI; CA expanded scope SB 1488 2022; NY no oral; check state board annually). Block out-of-scope orders (e.g., laser SLT in NY).
- Optical-shop AI conversion — Generate frame recommendation from face shape + Rx + lifestyle + budget + insurance allowance, with PD + seg height + base curve + corridor measurement via Visioffice + Topology + EyeQue. Output multi-pair quote (distance + computer + reading + sunwear) with insurance and out-of-pocket breakdown.
- State-compliant AI-scribe consent — Draft consent flow per CA AB 3030 + TX SB 815 + UT HB 452 + IL HB 1806 + FSMB Model Policy on AI 2024 + state OD board AI guidance. Distinguish ambient AI listening vs. patient-facing AI vs. autonomous AI-SaMD (IDx-DR), with opt-out preserved.
- Owner monthly scorecard — Track exams/OD-day, optical capture rate, multi-pair rate, contact-lens annual supply rate, recall + recare rate, denial rate, MIPS measure performance, Rx-release audit, online review velocity, FTC Endorsement Guides + Fake Reviews Rule 16 CFR 465 $51,744/violation FY 2026 ad audit.
The 12-Item Optometry Compliance Floor
- HIPAA Privacy + Security + Breach Notification 45 CFR 160 + 164 + BAA with every AI vendor
- FTC Eyeglass Rule 16 CFR 456 + Contact Lens Rule 16 CFR 315 + FCLCA 2020 amendment Rx release
- State OD board scope (TPA + glaucoma + lasers + oral medications) before AI auto-suggests
- AOA Code of Ethics + AOA Optometric Clinical Practice Guidelines
- State AI-scribe consent (CA AB 3030 + TX SB 815 + UT HB 452 + IL HB 1806) + FSMB Model Policy on AI 2024
- FDA AI-SaMD 510(k) + De Novo only (IDx-DR + EyeArt + AEYE within label) for autonomous decisions
- MIPS quality measures (Q117 DR + Q12 glaucoma + Q303 cataract + Q140/141 AMD + Q226 + Q128) if above threshold
- Promoting Interoperability with 2015-Edition CEHRT (RevolutionEHR + Compulink + Crystal PM)
- NCCI PTP/MUE edits (e.g., 92015 refraction with 92012/92014 + 25 modifier rules)
- AKS 42 USC §1320a-7b + Stark §1395nn + Sunshine $13.46/$134.49 FY 2026 on frame + lens lab + rep meals
- OSHA Bloodborne Pathogens 29 CFR 1910.1030 + state contact-lens dispensing + slit-lamp infection control
- FTC Endorsement Guides 2023 + Fake Reviews Rule 16 CFR 465 $51,744/violation FY 2026 + state UDAP
60-Day Rollout Plan
Days 1-15: BAA inventory + FTC Rx-release audit + state OD scope refresh; AI-scribe pilot one OD; baseline Q117 DR + Q12 glaucoma capture.
Days 16-30: Roll ambient scribe to all ODs; deploy FDA-cleared DR autonomous screening; baseline optical-shop capture and multi-pair rate.
Days 31-45: Prior-auth automation (vision + medical); state-compliant AI-scribe consent; optical-shop AI conversion live.
Days 46-60: Owner scorecard live; FTC Endorsement + Fake Reviews ad audit; state OD board AI guidance check; quarterly AI-SaMD reverify.
8 Mistakes That Kill Optometry AI Rollouts
- Letting AI auto-finalize Rx without OD review and signed FCLCA acknowledgment
- Gating Rx release behind paywall or upsell, violating FTC Eyeglass + Contact Lens Rules
- Using FDA-cleared autonomous AI (IDx-DR) outside label (e.g., type 1 patients under 22)
- Recommending lasers, oral medications, or surgery beyond state OD board scope
- Missing 25 modifier on E/M when same-day procedure (gonio + photos + OCT)
- Skipping AKS/Stark/Sunshine documentation on frame + lens lab + rep relationships
- Treating multi-pair dashboards as truth without validating against optical POS + actual gross profit
- Ignoring state AI-scribe consent statutes (CA + TX + UT + IL) and FSMB Model Policy on AI 2024
Frequently Asked Questions
What is the single biggest 2026 AI risk for an optometry practice?
Two tied: (1) FTC Eyeglass Rule 16 CFR 456 + Contact Lens Rule 16 CFR 315 (Fairness to Contact Lens Consumers Act, FCLCA) — Rx must be released to the patient automatically and free of charge after the eye exam, and contact lens Rx requires patient-signed confirmation or 8-hour passive-verification window per the 2020 FTC Final Rule. AI tools that gate or delay Rx release violate FTC; the 2020 amendment requires signed acknowledgment for paper Rx and explicit one-time digital opt-in. (2) State OD board scope of practice — therapeutic optometry (TPA), oral medications, glaucoma management, lasers (e.g., SLT, YAG, LPI), foreign-body removal, and minor surgical procedures vary widely (LA + KY + OK + AR allow lasers; CA OD scope expanded 2022 SB 1488; NY no oral). AI clinical decision support must be filtered to in-state OD scope before suggestions hit the chart.
Can ambient AI scribes document optometry SOAP notes correctly?
Yes — DAX Copilot, DeepScribe, Abridge, Suki, Heidi, Freed, Sunoh.ai support ambient scribe for ophthalmic exam with CPT 92002/92004 new + 92012/92014 established (general ophth), CPT 99202-99215 E/M (with 25 modifier when separate procedure), CPT 92015 refraction, CPT 92020 gonioscopy, CPT 92133 OCT optic nerve, CPT 92134 OCT macula, CPT 92250 fundus photos, CPT 92083 Humphrey VF, CPT 92285 corneal topography, CPT 92310-92313 CL fitting, ICD-10 H52 refractive error + H40 glaucoma + H35 retina + E11.31/E11.32/E11.34 diabetic retinopathy + H10 conjunctivitis. Output requires OD review + Rx audit; never auto-finalize Rx.
What MIPS measures and MVP should an optometry practice prioritize?
ODs who exceed MIPS thresholds (greater than $90K Medicare Part B + 200 patients + 200 services) must report. There is no optometry-specific MVP yet for 2025; ODs typically use Traditional MIPS or the Advancing Care for Heart Disease + Diabetes track for the diabetic-retinopathy measure. Quality measures: diabetic retinopathy exam (Q117), age-related macular degeneration (Q14 + Q140 + Q141), glaucoma optic nerve evaluation (Q12), cataract complication-free (Q303), POAG IOP reduction (Q141), tobacco screening (Q226), BMI (Q128). Improvement Activities: AI-assisted diabetic retinopathy screening + patient outreach. Promoting Interoperability requires 2015-Edition CEHRT (eClinicalWorks + Compulink + RevolutionEHR + Crystal PM + Officemate).
How does AI fit into glaucoma + diabetic retinopathy + AMD screening?
FDA-cleared AI-SaMD includes IDx-DR / Digital Diagnostics (autonomous diabetic retinopathy detection, first FDA-authorized De Novo 2018 + 510(k) updates), EyeArt by Eyenuk (510(k) DR), AEYE Diagnostic Imaging (DR), and Topcon NW-400 + DRS Plus + iCare DRSplus paired with grading services. For glaucoma: Heidelberg Spectralis + Zeiss Cirrus + Topcon Triton OCT with vendor AI (e.g., Glaucoma Module Premium Edition); progression analysis + GPA (Guided Progression Analysis) + GHT remain physician-graded. AI is decision support, not autonomous diagnosis (except IDx-DR for DR within label); the OD signs every diagnosis.
What is realistic ROI in 90 days?
Conservative targets: ambient scribe + refraction auto-draft → 30-60 minutes/day saved per OD + 1-2 more exams/day; AI prior-auth + denial appeal on Vision Service Plan + EyeMed + Davis Vision + Spectera + medical (BCBS + UHC + Aetna + Humana + Medicare Advantage) → 10-18 percent denial-rate reduction; AI optical-shop conversion (frame board + measurement + reorder) → 8-15 percent capture-rate lift; FDA-cleared DR autonomous screening → 25-40 percent more diabetic exams completed. Validate against EHR + claims + optical POS, not vendor dashboards.
Authoritative Sources
- AOA Code of Ethics + AOA Optometric Clinical Practice Guidelines
- FTC Eyeglass Rule 16 CFR 456 + Contact Lens Rule 16 CFR 315 + FCLCA 2020 amendment
- State OD board scope (TPA + oral medications + glaucoma + lasers + minor surgery)
- CMS MIPS quality measures (Q117 + Q12 + Q303 + Q140/141) and Promoting Interoperability
- FSMB Model Policy on AI 2024 + state AI-scribe statutes
- FDA AI-SaMD 510(k) + De Novo (IDx-DR + EyeArt + AEYE)
- NCCI PTP/MUE Policy Manual + AMA CPT 2026 + ICD-10-CM Oct 1 2025